Onyx®: A unique neuroembolic agent

Expert Review of Medical Devices

Volumn 3, Issue 6, 2006, Pages 705-715

  Ayad, Michael ^a   Eskioglu, Eric ^a   Mericle, Robert A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cerebral arteriovenous malformation; Embolic agent; Endovascular; Ethylene vinyl alcohol copolymer

Indexed keywords

DIMETHYL SULFOXIDE; ENBUCRILATE; ETHYLENE VINYL ALCOHOL COPOLYMER; ONYX COPOLYMER; POLYVINYL DERIVATIVE;

ARTICLE; BLEEDING; BRAIN ARTERIOVENOUS MALFORMATION; CHEMICAL COMPOSITION; CHEMOEMBOLIZATION; CLINICAL TRIAL; DEATH; FOOD AND DRUG ADMINISTRATION; HUMAN; INTRACRANIAL ANEURYSM; POSTOPERATIVE COMPLICATION; SAFETY; UNITED STATES; VASCULAR SURGERY; ARTIFICIAL EMBOLISM; BRAIN HEMORRHAGE; CONTROLLED CLINICAL TRIAL; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ONYX;

CEREBRAL HEMORRHAGE; DIMETHYL SULFOXIDE; EMBOLIZATION, THERAPEUTIC; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; POLYVINYLS; RANDOMIZED CONTROLLED TRIALS;

EID: 33845877450     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.3.6.705     Document Type: Article

References (32)

1. Stapf C, Mohr JP, Pile-Spellman J, Solomon RA, Sacco RL, Connolly ES. Epidemiology and natural history of arteriovenous malformations. Neurosurg. Focus 11(5), 1-5 (2005).
2. Pawlikowska L, Tran MN, Achrol AS et al. Polymorphisms in transforming growth factor-(β)-related genes ALK1 and ENG are associated with sporadic brain arteriovenous malformations. Stroke 36, 2278-2280 (2005).
3. Fults D, Kelly DL Jr. Natural history of arteriovenous; malformations of the brain: a clinical study. Neurosurgery 15(5), 658-662 (1984).
4. Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J. Neurosurg. 73, 387-391 (1990).
5. Frizzel RT, Fisher WS III. Cure, morbidity, and mortality associated with embolization of brain arteriovenous malformations: a review of 1246 patients in 32 series over a 35-year period. Neurosurgery 37(6), 1031-1039 (1995)
6. Ledezma CJ, Hoh BL, Carter BS, Pryor JC, Putman CM, Ogilvy CS. Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors. Neurosurgery 58(4), 602-611 (2006).
7. Spetzler RF, Wilson CB, Weinstein P et al. Normal perfusion pressure breakthrough theory. Clin. Neurosurg. 25, 651-672 (1978).
8. Connors JJ III, Wojac JC. Fundamentals of interventional neuroradiology: tools of the trade. Chapter 1. In: Interventional Neuroradiology - Strategies and Practical Techniques. Connors JJ, Wojac JC (Eds). W.B. Saunders, PA, USA, 1-43 (1999).
9. Kerber CW, Wong W. Liquid acrylic adhesive agents in interventional neuroradiology. Neurosurg Clin. N. Am 11(1), 85-99 (2000).
10. Taki W, Yonekawa Y, Iwata H et al. A new liquid material for embolization of arteriovenous malformations. AJNR 11, 163-168 (1990).
11. Terada T, Nakamura Y, Nakai K et al. Embolization of arteriovenous malformations with peripheral aneurysms using ethylene vinyl alcohol copolymer. J. Neurosurg. 75, 655-660 (1991).
12. Chaloupka JC, Vinuela F, Vinters HV, Robert J. Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model. AJNR 15, 1107-1115 (1994).
13. Yamashita K, Taki W, Iwata H et al. Characteristics of ethylene vinyl alcohol copolymer (EVAL) mixtures. AJNR 15, 1103-1105 (1994).
14. Murayama Y, Vinuela F, Ulhoa A et al. Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 43(5), 1164-1175 (1998).
15. Chaloupka JC, Huddle DC, Alderman J et al. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR 20, 401-410 (1999).
16. Pamuk AG, Saatci I, Cekirge HS, Aypur U. A contribution to the controversy over dimethyl sulfoxide toxicity: anesthesia monitoring results in patients treated with Onyx embolization for intracranial aneurysms. Neuroradiology 47, 380-386 (2005).
17. Saatci I, Cekirge S, Ciceri EFM et al. CT and MRI imaging findings and their implication in the follow-up of patients with intracranial aneurysms treated with endosaccular occlusion with Onyx. AJNR 24, 567-578 (2003).
18. Akin ED, Perkins E, Ross IB. Surgical handling characteristics of an ethylene vinyl alcohol copolymer compared with N-butyl cyanoacrylate used for embolization of vessels in an arteriovenous malformation resection model in swine. J. Neurosurg. 98, 366-370 (2003).
19. Howington JU, Kerber CW, Hopkins LN. Liquid embolic agents in the treatment of intracranial arteriovenous malformations. Neurosurg. Clin. N. Am. 16, 355-363 (2005).
20. Jahan R, Murayama Y, Gobin YP et al. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 48(5), 984-997 (2001).
21. Higashida R. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients [comment]. Neurosurgery 48, 995 (2001).
22. Lagares A, Lobarto RD, Ricoy JR, Campollo J. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients [comment]. Neurosurgery 51, 1525-1526 (2002).
23. Molyneux AJ, Cekirge S, Saatci I, Gail G. Cerebral Aneurysm Multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20 European centers. AJNR 25, 39-51 (2004).
24. Cekirge HS, Saatci I, Ozturk MH et al. Late angiographic and clinical follow-up results of 100 consecutive aneurysms treated with Onyx reconstruction: largest single-center experience. Neuroradiology 48(2), 113-126 (2006).
25. Murayama Y, Nien YL, Duckwiler G et al. Guglielmi detachable coil embolization of cerebral aneurysms: 11 years' experience. J. Neurosurg. 98, 959-966 (2003).
26. Murayama Y, Vinuela F, Tateshima S, Vinuela F Jr, Akiba Y. Endovascular treatment of experimental aneurysms by use of a combination of liquid embolic agents and protective devices. AJNR 21, 1726-1735 (2000).
27. Warakaulle DR, Aviv RI, Niemann D et al. Embolisation of spinal dural arteriovenous fistulae with Onyx. Neuroradiology 45, 110-112 (2003).
28. Arat A, Cekirge S, Saatci I, Ozgen B. Transvenous injection of Onyx for casting of the cavernous sinus for the treatment of a carotid-cavernous fistula. Neuroradiology 46, 1012-1015 (2004).
29. Suzuki S, Lee DW, Jahan R, Duckwiler GR, Vinuela F. Transvenous treatment of spontaneous dural carotid-cavernous fistulas using a combination of detachable coils and Onyx. AJNR 27, 1346-1349 (2006).
30. Gobin YP, Murayama Y, Milanese K et al. Head and neck hypervascular lesions: embolization with ethylene vinyl alcohol copolymer - laboratory evaluation in swine and clinical evaluation in humans. Radiology 221, 309-317 (2001).
31. Hamada J, Kai Y, Kazekawa K et al. A nonadhesive liquid embolic agent composed of ethylene vinyl alcohol copolymer and ethanol mixture for the treatment of cerebral arteriovenous malformations: experimental study. J. Neurosurg. 97(4), 889-895 (2002).
32. Hamada J, Kai Y, Morioka K et al. A mixture of ethylene vinyl alcohol copolymer and ethanol yielding a nonadhesive liquid embolic agent to treat cerebral arteriovenous malformations: initial clinical experience. J. Neurosurg. 97(4), 881-888 (2002).